Transcode Therapeutics | 10-Q:2024财年三季报
Transcode Therapeutics | DEFA14A:其他
Transcode Therapeutics | DEFA14A:其他
Transcode Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-3i, LP(0%),3i Management LLC(0%)等
Transcode Therapeutics | 8-K:重大事件
Transcode Therapeutics | DEF 14A:股东委托书决议
Transcode Therapeutics | PRE 14A:并购重组委托声明
Transcode Therapeutics | 8-K:重大事件
Transcode Therapeutics | 8-K:重大事件
Transcode Therapeutics | 8-K:重大事件
Transcode Therapeutics | 10-Q:2024财年二季报
Transcode Therapeutics | SC 13G:超过5%持股股东披露文件-3i, LP(9.9%),3i Management LLC(9.9%)等
Transcode Therapeutics | 8-K:重大事件
Transcode Therapeutics | 424B5:募资说明书
Transcode Therapeutics | 424B5:募资说明书
Transcode Therapeutics | SC 13D:超过5%持股股东披露文件-Thomas A. Fitzgerald(5.5%)
Transcode Therapeutics | 4:持股变动声明-高管 Fitzgerald Thomas A
Transcode Therapeutics | 4:持股变动声明-董事 Manting Erik
Transcode Therapeutics | 4:持股变动声明-董事 Marquet Magda
Transcode Therapeutics | 4:持股变动声明-董事 Calais Philippe
暂无数据
暂无数据